Jinzi J. Wu - Concepedia

Author

Jinzi J. Wu

University of Arizona

Also Known As

J. WU, J. Wu, JINZI WU, Jinzi J Wu, Jinzi J. Wu, Jinzi Wu, Wu, J.J., Wu, Jinzi J

Publications

1.7K

Citations

H-Index

Concepts

All Affiliations

University of Arizona McGill University Health Centre Sichuan University The Sixth People's Hospital of Shenyang Beijing YouAn Hospital

About

Jinzi J. Wu is an author at University of Arizona specializing in medicine, pharmacology, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	14	775
2	Biochemistry	7	7	253
3	Natural Sciences	5	5	133
4	Engineering	1	1	11
5	Biomolecular Engineering	1	1	18

Jinzi J. Wu

Publications

1.5K

Citations

H-Index

Page 1

	Year	Citations
Antimicrobial drug discovery through bacteriophage genomics Jing Liu, Mohammed Dehbi, Greg Moeck, Nature Biotechnology Antimicrobial Drug DiscoveryAntibioticsBacteriophageMicrobiologyAntimicrobial Pharmacokinetics	2004	233
Nanoparticles Targeted With NGR Motif Deliver c-myc siRNA and Doxorubicin for Anticancer Therapy Yunching Chen, Jinzi J. Wu, Leaf Huang Molecular Therapy	2010	181
Identifying Substrate Motifs of Protein Kinases by a Random Library Approach Jinzi J. Wu, N. Qingyan, Kit S. Lam Biochemistry	1994	103
Comparison of Assay Technologies for a Tyrosine Kinase Assay Generates Different Results in High Throughput Screening Matthew A. Sills, Donna Weiss, Quynhchi Pham, SLAS DISCOVERY Signal TransductionBiochemistryHigh Throughput ScreeningAssay TechnologiesMedicine	2002	99
Binding and internalization of NGR-peptide-targeted liposomal doxorubicin (TVT-DOX) in CD13-expressing cells and its antitumor effects Seema V. Garde, André J. Forté, Michael Long Ge, Anti-Cancer Drugs Drug TargetingTvt-dox FormulationCd13-expressing CellsMedicineImmunology	2007	93
Enhanced Antitumor Efficacy of Clinical-Grade Vasculature-Targeted Liposomal Doxorubicin Fabio Pastorino, Daniela Di Paolo, Federica Piccardi, Clinical Cancer Research	2008	92
First clinical study using HCV protease inhibitor danoprevir to treat COVID-19 patients Hongyi Chen, Zhicheng Zhang, Li Wang, Medicine	2020	89
Lysine sulfonamides as novel HIV-protease inhibitors: Nε-Acyl aromatic α-amino acids Brent R. Stranix, Jean-François Lavallée, Guy Sévigny, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryAntiviral CompoundBiochemistryNatural SciencesMedicine	2006	82
First Clinical Study Using HCV Protease Inhibitor Danoprevir to Treat Naïve and Experienced COVID-19 Patients Hongyi Chen, Zhicheng Zhang, Li Wang, Viral Polymerase StructureImmunotherapeuticsHiv ProteasesAntiviral DrugCovid-19	2020	80
Identification and characterization of a novel synthetic peptide substrate specific for Src‐family protein tyrosine kinases Kit S. Lam, Jinzi J. Wu, Qiang Lou International journal of peptide & protein research	1995	77

Page 1